6CM
TOVX icon

683 Capital Management’s Theriva Biologics TOVX Stock Holding History

683 Capital Management’s Portfolio TOVX Stock Details TOVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-171
Closed -$19K – 192
2019
Q3 		$19K Hold
171
– – ﹤0.01% 149
2019
Q2 		$24K Hold
171
– – ﹤0.01% 168
2019
Q1 		$29K Hold
171
– – ﹤0.01% 161
2018
Q4 		$24K Hold
171
– – ﹤0.01% 185
2018
Q3 		$111K Hold
171
– – 0.01% 134
2018
Q2 		$359K Hold
171
– – 0.05% 114
2018
Q1 		$478K Hold
171
– – 0.07% 108
2017
Q4 		$762K Buy
+171
New +$1.07M 0.12% 112

Other funds holding TOVX

SM
Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
BFM
Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SCA
Snowden Capital Advisors New York $3.76B AUM 23.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return